Literature DB >> 15849369

Complications of HIV disease and antiretroviral therapy.

Judith S Currier1, Diane V Havlir.   

Abstract

Metabolic, opportunistic, and other infectious complications of HIV infection and antiretroviral therapy continue to be major areas of active investigation. This year's Conference on Retroviruses and Opportunistic Infections included many important presentations on the clinical aspects of HIV complications. In each successive year, the studies reported in the area of complications have matured and now include more randomized trials evaluating interventions for the management of HIV complications and more well-designed observational studies with long-term follow-up. This article will review new data presented on metabolic complications, including cardiovascular risk, lipid disorders and lipoatrophy, renal complications, hepatic complications (hepatitis B and C virus infections), tuberculosis, and other bacterial infections.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15849369

Source DB:  PubMed          Journal:  Top HIV Med        ISSN: 1542-8826


  2 in total

1.  Tuberculosis treatment and risk of stavudine substitution in first-line antiretroviral therapy.

Authors:  Daniel J Westreich; Ian Sanne; Mhairi Maskew; Babatyi Malope-Kgokong; Francesca Conradie; Pappie Majuba; Michele Jonsson Funk; Jay S Kaufman; Annelies Van Rie; Patrick Macphail
Journal:  Clin Infect Dis       Date:  2009-06-01       Impact factor: 9.079

2.  Development of a liposomal nanodelivery system for nevirapine.

Authors:  Lakshmi N Ramana; Swaminathan Sethuraman; Udaykumar Ranga; Uma M Krishnan
Journal:  J Biomed Sci       Date:  2010-07-13       Impact factor: 8.410

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.